Rui O. Costa

Rui O. Costa

Auto-generated profile, based on publicly available information

Rui O. Costa

CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra , 3004-504 Coimbra

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Neurobiology of Disease
Verified
Journal Article
Closed access
Elisabete FerreiroElisabete Ferreiro
Elisabete Ferreiro
Rosa ResendeRosa Resende
Rosa Resende
RCRui Costa
Rui Costa
COCatarina R. Oliveira
Catarina R. Oliveira
CPCláudia Maria F. Pereira
Cláudia Maria F. Pereira

1 July 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
Sandra MotaSandra Mota
Sandra Mota
RCRui O. Costa
Rui O. Costa
IFIldete Luísa Ferreira
Ildete Luísa Ferreira
ISIsabel Santana
Isabel Santana
GCGladys L. Caldeira
Gladys L. Caldeira
Ana Cristina Cristina RegoAna Cristina Cristina Rego
Ana Cristina Cristina Rego

4 June 2012 in International Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Elisabete FerreiroElisabete Ferreiro
Elisabete Ferreiro
IBInes Baldeiras
Ines Baldeiras
IFIldete Luísa Ferreira
Ildete Luísa Ferreira
RCR. O. Costa
R. O. Costa
Ana Cristina Cristina RegoAna Cristina Cristina Rego
Ana Cristina Cristina Rego
COC. R. Oliveira
C. R. Oliveira
Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting several million of people worldwide. Pathological changes in the AD brain include the presence of amyloid plaques, neurofibrillary tangles, loss of neurons and synapses, and oxidative damage. These changes strongly associate with mitochondrial dysfunction and stress of the endoplasmic reticulum (ER). Mitochondrial dysfunction is intimately linked to the production of reactive oxygen species (ROS) and mitochondrial-driven apoptosis, which appear to be aggravated in the brain of AD patients. Concomitantly, mitochondria are closely associated with ER, and the deleterious crosstalk between both organelles has been shown to be involved in neuronal degeneration in AD. Stimuli that enhance expression of normal and/or folding-defective proteins activate an adaptive unfolded protein response (UPR) that, if unresolved, can cause apoptotic cell death. ER stress also induces the generation of ROS that, together with mitochondrial ROS and decreased activity of several antioxidant defenses, promotes chronic oxidative stress. In this paper we discuss the critical role of mitochondrial and ER dysfunction in oxidative injury in AD cellular and animal models, as well as in biological fluids from AD patients. Progress in developing peripheral and cerebrospinal fluid biomarkers related to oxidative stress will also be summarized.

18 June 2012 in Aging Cell
Verified
Journal Article
Open access
PDF file
RCRui O. Costa
Rui O. Costa
PLPascale N. Lacor
Pascale N. Lacor
IFIldete Luísa Ferreira
Ildete Luísa Ferreira
Rosa ResendeRosa Resende
Rosa Resende
YAYves P. Auberson
Yves P. Auberson
CPCláudia Maria F. Pereira
Cláudia Maria F. Pereira
Summary: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting both the hippocampus and the cerebral cortex. Reduced synaptic density that occurs early in the disease process seems to be partially due to the overactivation ofN‐methyl‐d‐aspartate receptors (NMDARs) leading to excitotoxicity. Recently, we demonstrated that amyloid‐beta oligomers (AβO), the species implicated in synaptic loss during the initial disease stages, induce endoplasmic reticulum (ER) stress in cultured neurons. Here, we investigated whether AβO trigger ER stress by an NMDAR‐dependent mechanism leading to neuronal dysfunction and analyzed the contribution of GluN2A and GluN2B subunits of this glutamate receptor. Our data revealed that AβO induce ER stress in mature hippocampal cultures, activating ER stress‐associated sensors and increasing the levels of the ER chaperone GRP78. We also showed that AβO induce NADPH oxidase (NOX)‐mediated superoxide production downstream of GluN2B and impairs ER and cytosolic Ca2+homeostasis. These events precede changes in cell viability and activation of the ER stress‐mediated apoptotic pathway, which was associated with translocation of the transcription factor GADD153 / CHOP to the nucleus and occurred by a caspase‐12‐independent mechanism. Significantly, ER stress took place after AβO interaction with GluN2B subunits. In addition, AβO‐induced ER stress and hippocampal dysfunction were prevented by ifenprodil, an antagonist of GluN2B subunits, while the GluN2A antagonist NVP‐AAM077 only slightly attenuated AβO‐induced neurotoxicity. Taken together, our results highlight the role of GluN2B subunit of NMDARs on ER stress‐mediated hippocampal dysfunction caused by AβO suggesting that it might be a potential therapeutic target during the early stages of AD.

7 March 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
MMMiranda Mele
Miranda Mele
RCRui O. Costa
Rui O. Costa
CDCarlos Duarte
Carlos Duarte
GABAA receptors (GABAAR) are the major players in fast inhibitory neurotransmission in the central nervous system (CNS). Regulation of GABAAR trafficking and the control of their surface expression play important roles in the modulation of the strength of synaptic inhibition. Different pieces of evidence show that alterations in the surface distribution of GABAAR and dysregulation of their turnover impair the activity of inhibitory synapses. A diminished efficacy of inhibitory neurotransmission affects the excitatory/inhibitory balance and is a common feature of various disorders of the CNS characterized by an increased excitability of neuronal networks. The synaptic pool of GABAAR is mainly controlled through regulation of internalization, recycling and lateral diffusion of the receptors. Under physiological condition these mechanisms are finely coordinated to define the strength of GABAergic synapses. In this review article, we focus on the alteration in GABAAR trafficking with an impact on the function of inhibitory synapses in various disorders of the CNS. In particular we discuss how similar molecular mechanisms affecting the synaptic distribution of GABAAR and consequently the excitatory/inhibitory balance may be associated with a wide diversity of pathologies of the CNS, from psychiatric disorders to acute alterations leading to neuronal death. A better understanding of the cellular and molecular mechanisms that contribute to the impairment of GABAergic neurotransmission in these disorders, in particular the alterations in GABAAR trafficking and surface distribution, may lead to the identification of new pharmacological targets and to the development of novel therapeutic strategies.

23 June 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LMLuís F. Martins
Luís F. Martins
RCRui O. Costa
Rui O. Costa
JPJoana R. Pedro
Joana R. Pedro
PAPaulo Aguiar
Paulo Aguiar
SSSofia C. Serra
Sofia C. Serra
RARamiro De Almeida
Ramiro De Almeida
Mesenchymal stem cells (MSCs) have been used for cell-based therapies in regenerative medicine, with increasing importance in central and peripheral nervous system repair. However, MSCs grafting present disadvantages, such as, a high number of cells required for transplantation and low survival rate when transplanted into the central nervous system (CNS). In line with this, MSCs secretome which present on its composition a wide range of molecules (neurotrophins, cytokines) and microvesicles, can be a solution to surpass these problems. However, the effect of MSCs secretome in axonal elongation is poorly understood. In this study, we demonstrate that application of MSCs secretome to both rat cortical and hippocampal neurons induces an increase in axonal length. In addition, we show that this growth effect is axonal intrinsic with no contribution from the cell body. To further understand which are the molecules required for secretome-induced axonal outgrowth effect, we depleted brain-derived neurotrophic factor (BDNF) from the secretome. Our results show that in the absence of BDNF, secretome-induced axonal elongation effect is lost and that axons present a reduced axonal growth rate. Altogether, our results demonstrate that MSCs secretome is able to promote axonal outgrowth in CNS neurons and this effect is mediated by BDNF.